{{Rsnum
|rsid=8192719
|Gene=CYP2B6
|Chromosome=19
|position=41012868
|Orientation=plus
|GMAF=0.2727
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CYP2B6
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 51.3 | 41.6 | 7.1
| HCB | 65.7 | 29.9 | 4.4
| JPT | 64.6 | 29.2 | 6.2
| YRI | 33.3 | 49.0 | 17.7
| ASW | 46.4 | 46.4 | 7.1
| CHB | 65.7 | 29.9 | 4.4
| CHD | 69.7 | 27.5 | 2.8
| GIH | 35.6 | 43.6 | 20.8
| LWK | 45.4 | 40.7 | 13.9
| MEX | 46.6 | 50.0 | 3.4
| MKK | 38.7 | 48.4 | 12.9
| TSI | 50.0 | 40.2 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20639527
|Title=Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort
|OA=1
}}

{{PMID|19239339|OA=1
}} Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans.

{{PMID|19652719|OA=1
}} Univariate/multivariate genome-wide association scans using data from families and unrelated samples.

{{PMID|19659438|OA=1
}} CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti.

{{PMID|19702646|OA=1
}} Tests of association for quantitative traits in nuclear families using principal components to correct for population stratification.

{{PMID|19956578|OA=1
}} Family-based bivariate association tests for quantitative traits.

{{PMID|20017988|OA=1
}} A comparative study of three methods for detecting association of quantitative traits in samples of related subjects.

{{PMID|20017990|OA=1
}} Family-based genome-wide association study for simulated data of Framingham Heart Study.

{{PMID|20018031|OA=1
}} The Genetic Analysis Workshop 16 Problem 3: simulation of heritable longitudinal cardiovascular phenotypes based on actual genome-wide single-nucleotide polymorphisms in the Framingham Heart Study.

{{PMID|21245293|OA=1
}} Correlated genotypes in friendship networks.

{{PMID Auto
|PMID=23249875
|Title=Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels:  a CYP2B6 gene resequencing study
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}